Journal article
Leucine-rich alpha-2-glycoprotein-1 is upregulated in sera and tumors of ovarian cancer patients
Abstract
BackgroundNew biomarkers that replace or are used in conjunction with the current ovarian cancer diagnostic antigen, CA125, are needed for detection of ovarian cancer in the presurgical setting, as well as for detection of disease recurrence. We previously demonstrated the upregulation of leucine-rich alpha-2-glycoprotein-1 (LRG1) in the sera of ovarian cancer patients compared to healthy women using quantitative mass spectrometry.MethodsLRG1 …
Authors
Andersen JD; Boylan KL; Jemmerson R; Geller MA; Misemer B; Harrington KM; Weivoda S; Witthuhn BA; Argenta P; Vogel RI
Journal
Journal of Ovarian Research, Vol. 3, No. 1,
Publisher
Springer Nature
Publication Date
12 2010
DOI
10.1186/1757-2215-3-21
ISSN
1757-2215